Clinical Trials Logo

Clinical Trial Summary

comparing between the effect of intradermal injection of TXA and low power low density fractional CO2 lasers on post acne hyperpigmentation


Clinical Trial Description

Randomized controlled split-face study. One side of the face will be assigned to TXA intradermal microinjection using Kapron 500mg/5ml ampoules (Amoun Pharmaceutical Company), the dose of 1 ml syringe with 100mg/ml. TXA will be prepared under sterile conditions. Injections will be applied intradermally on hyperpigmented areas at 1cm intervals. The injection will be repeated every two weeks for three months. The other side of the face will be randomly assigned to low power fractional CO2 laser with a power of 12 watts, spacing 700 micrometers (low density), and dwell time 300 microsecond every four weeks for three months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03765021
Study type Interventional
Source Cairo University
Contact
Status Not yet recruiting
Phase N/A
Start date December 2018
Completion date July 2019

See also
  Status Clinical Trial Phase
Terminated NCT05327361 - LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP) Phase 2
Not yet recruiting NCT03850119 - Nanofat on Wound Healing and Scar Formation N/A
Not yet recruiting NCT05883657 - Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation) N/A
Completed NCT03402893 - The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color Phase 4
Completed NCT04704245 - Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines N/A
Completed NCT02492373 - Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser N/A
Completed NCT05704114 - Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne Phase 4
Completed NCT01038869 - Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH) Phase 4
Not yet recruiting NCT06361251 - Interventional, Monocentric, Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post -Inflammatory Hyperpigmentation (Pih)) on the Face N/A
Not yet recruiting NCT06305897 - Evaluation of the Tolerance (Main Objective) and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) on the Face N/A